These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1523980)

  • 1. [Clinical study of prophylactic therapy of interferon on postoperative renal cell carcinoma].
    Yasumoto R; Asakawa M; Hayahara N; Maekawa T; Wada S; Kishimoto T; Maekawa M; Morikawa Y; Kawakita J; Umeda M
    Hinyokika Kiyo; 1992 Mar; 38(3):267-75. PubMed ID: 1523980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
    Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
    Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of postoperative interferon-alpha adjuvant therapy for non-metastatic renal cell carcinoma.
    Gotoh A; Shirakawa T; Hinata N; Wada Y; Hara I; Fujisawa M; Kawabata G; Okada H; Arakawa S; Kamidono S
    Int J Urol; 2004 May; 11(5):257-63. PubMed ID: 15147539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant interferon alpha in renal carcinoma with a high risk of recurrence. Multicenter pilot study].
    Pizzocaro G; Piva L; Faustini M; Nicolai N; Salvioni R; Pisani E; Maggioni A; Mandressi A; Dormia E; Minervini S
    Arch Ital Urol Androl; 1993 Apr; 65(2):173-6. PubMed ID: 8330063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.
    Messing EM; Manola J; Wilding G; Propert K; Fleischmann J; Crawford ED; Pontes JE; Hahn R; Trump D;
    J Clin Oncol; 2003 Apr; 21(7):1214-22. PubMed ID: 12663707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survival analysis of interferon-alpha on locally advanced clear cell renal cell carcinoma after radical nephrectomy].
    Xia J; Li X; Chen XQ; Li X; Zeng H; Wei Q; Zhang P; Zhu YC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):91-4. PubMed ID: 22455140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma.
    Kriegmair M; Oberneder R; Hofstetter A
    Urology; 1995 May; 45(5):758-62. PubMed ID: 7747370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
    Kinouchi T; Meguro N; Maeda O; Saiki S; Kuroda M; Usami M; Kotake T
    Int J Urol; 1996 Jan; 3(1 Suppl):S41-3. PubMed ID: 24304021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Presentation of a randomized multicenter study protocol. "Evaluation of adjuvant interferon effectiveness after radical nephrectomy in kidney carcinoma with high risk of relapse"].
    Arch Ital Urol Nefrol Androl; 1990 Mar; 62(1):177-83. PubMed ID: 2141713
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intralesional and transarterial administration of interferon for renal cell carcinoma].
    Kitagawa R; Fujime M; Sakamoto Y; Hanazawa K; Fujita K; Isobe H
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1462-5. PubMed ID: 1530294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of low dosage cyclic interferon-gamma therapy of metastatic renal cell carcinoma].
    Hofmockel G; Wirth MP; Heimbach D; Frohmüller HG
    Urologe A; 1993 Jul; 32(4):290-4. PubMed ID: 8372410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of renal cell carcinoma with interferons].
    Oya M
    Nihon Rinsho; 2006 Jul; 64(7):1281-5. PubMed ID: 16838645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.
    van Herpen CM; Jansen RL; Kruit WH; Hoekman K; Groenewegen G; Osanto S; De Mulder PH
    Br J Cancer; 2000 Feb; 82(4):772-6. PubMed ID: 10732744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two cases of hyperthyroidism induced by interferon-alpha therapy for renal cell carcinoma].
    Umemoto S; Izumi K; Kanno H
    Hinyokika Kiyo; 2007 Apr; 53(4):225-9. PubMed ID: 17515071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon as adjunctive treatment for non-metastatic renal cell carcinoma.
    Takahashi S; Tanigawa T; Imagawa M; Mimata H; Nomura Y; Ogata J
    Br J Urol; 1994 Jul; 74(1):11-4. PubMed ID: 8044505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
    Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
    Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous administration of interferon alpha and gamma in patients with metastatic renal cell carcinoma.
    Koga S; Nishikido M; Matsuya F; Kanetake H; Saito Y
    Anticancer Res; 1999; 19(6C):5547-50. PubMed ID: 10697614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.